Loading...

Table of Content

    20 April 2022, Volume 17 Issue 04
    Face to the Challenge — Vascular Parkinsonism
    WANG Yi
    2022, 17(04):  327-332.  DOI: 10.3969/j.issn.1673-5765.2022.04.001
    Asbtract ( )   PDF (2198KB) ( )  
    References | Related Articles | Metrics
    Vascular Parkinsonism
    WANG Yi
    2022, 17(04):  333-333. 
    Asbtract ( )   PDF (1645KB) ( )  
    Related Articles | Metrics
    Expert Consensus on Diagnosis and Treatment of Vascular Parkinsonism with Integrated Traditional Chinese and Western Medicine 2022
    Neuromedicine Branch, Chinese Geriatrics Society
    2022, 17(04):  334-340.  DOI: 10.3969/j.issn.1673-5765.2022.04.002
    Asbtract ( )   PDF (2091KB) ( )  
    References | Related Articles | Metrics
    Comparison of Cognitive Function between Vascular Parkinsonism and Parkinson’s Disease
    SHI Songxin, WANG Dali, LI Hong, WANG Xingwen, ZI Yuan, AN Yachen, ZHANG Jiang
    2022, 17(04):  341-345.  DOI: 10.3969/j.issn.1673-5765.2022.04.003
    Asbtract ( )   PDF (2420KB) ( )  
    References | Related Articles | Metrics
    Objective To compare the cognitive function between the patients with vascular parkinsonism (VaP) and Parkinson's disease (PD). Methods PD patients and VaP patients who were firstly admitted in North China University of Science and Technology Affiliated Hospital from January 2018 to December 2020 were enrolled in the retrospective study. MMSE and MoCA were used to evaluate the patients’ cognitive function, and the unified Parkinson's disease rating scale part Ⅲ (UPDRS Ⅲ) was used to evaluate the motor function. The scores of MMSE, MoCA, UPDRS Ⅲ and baseline characteristics between PD patients and VaP patients were compared. Cognitive impairment was defined as MoCA<26. The differences in the above scores between VaP patients with cognition impairment (VPCI) and PD patients with cognition impairment (PDCI) were compared. Results A total of 19 VaP patients and 22 PD patients were enrolled in this study. VaP patients had higher incidence of hypertension (78.9% vs . 40.9%, P =0.014), diabetes (52.6% vs . 22.7%, P =0.047) and leukodystrophy (84.2% vs . 36.4%, P =0.002) than PD patients, while PD patients had higher incidence of hyperhomocysteinemia than VaP patients (72.7% vs . 36.8%, P =0.021); VaP patients had higher incidence of cognitive impairment (78.9% vs . 45.5%, P =0.028) and lower scores of MMSE (24.0 vs . 29.0, P <0.001), MoCA (17.0 vs . 26.0, P =0.002) and UPDRS Ⅲ (18.0 vs . 33.5, P <0.001) than PD patients. VPCI patients had lower scores of MMSE (23.0 vs . 27.0, P =0.002), MoCA (17.0 vs . 22.0, P =0.041) and UPDRS Ⅲ (18.0 vs . 37.0, P =0.004) than PDCI patients. Conclusions VaP patients had higher incidence of cognition impairment and more severer cognition impairment than PD patients.
    Progress of Vascular Parkinsonism
    YE Yichao, YU Shi, SHE Yajun, FANG Zheng, WANG Yi
    2022, 17(04):  346-350.  DOI: 10.3969/j.issn.1673-5765.2022.04.004
    Asbtract ( )   PDF (1911KB) ( )  
    References | Related Articles | Metrics
    Vascular parkinsonism (VaP) is a common secondary Parkinson's syndrome, which is caused by hypoxia of basal ganglia neuron network, metabolic abnormal, and destroy of neural microenvironment caused by cerebral small vessels injury. The clinical manifestations of VaP are related to vascular injury, and the risk factors, etiology and clinical manifestations of which are significantly different from that of Parkinson's disease (PD). However, as they have some common symptoms, VaP and PD may be misdiagnosed clinically. The development of auxiliary examination technology is helpful for the diagnosis of VaP. For example, the volume of white matter hyperintensity (WMH) in caudate nucleus, basal ganglia and subcortical areas measured by brain MRI, and substantia nigra imaging on SWI can help distinguish VaP from PD. In addition, some new technologies such as molecular imaging and neural network gait pattern assessment based on gait time series can also help distinguish VaP from PD.
    Vascular Parkinsonism: A Case Report and Literature Review
    HE Zhonghui, PAN Yujun, JIANG Hongquan
    2022, 17(04):  351-353.  DOI: 10.3969/j.issn.1673-5765.2022.04.005
    Asbtract ( )   PDF (2506KB) ( )  
    References | Related Articles | Metrics
    Analysis on Risk Factors for Total Cerebral Small Vessel Disease Burden in Patients with Dizziness or Vertigo
    ZHU Cuiting, HU Wenli
    2022, 17(04):  354-359.  DOI: 10.3969/j.issn.1673-5765.2022.04.006
    Asbtract ( )   PDF (2138KB) ( )  
    References | Related Articles | Metrics
    Objective To explore the risk factors for the total cerebral small vessel disease (CSVD) burden in patients with dizziness or vertigo. Methods This retrospective study enrolled consecutive patients with dizziness or vertigo who were admitted in Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University from May 2021 to December 2021. All patients completed routine laboratory examination, vestibular function examinations (including Dix-hallpike test or roll test) and brain MRI. The final diagnosis and total CSVD burden score were recorded. The clinical data of patients in different load score groups (0, 1, 2, 3 and 4 score groups) were compared. Logistic regression model was used to identify the related risk factors of total CSVD burden in patients with dizziness or vertigo. Results A total of 210 eligible patients were included, with an average age of 66.9±10.7 years and 101 males (48.1%). Finally, there were 81 cases (38.6%) in 0 score group, 78 cases (37.1%) in 1 score group, 23 cases (11.0%) in 2 score group, 19 cases (9.0%) in 3 score group and 9 cases (4.3%) in 4 score group. Univariate analysis showed that there were statistical differences in age, hypertension, diabetes, history of ischemic stroke, smoking, glycosylated hemoglobin and the level of Hcy in different CSVD burden score groups. Logistic regression analysis showed that the smoking (OR 2.386, 95%CI 1.232-4.623, P =0.010) and hypertension (OR 1.979, 95%CI 1.084-3.612,

    P =0.026) were independent risk factors of total CSVD burden in patients with dizziness or vertigo.

    Conclusions Smoking and hypertension were independent risk factors for the total CSVD burden in patients with dizziness or vertigo.

    Comparative Observation of Functional Near-Infrared Brain Imaging in Stroke Patients with Unilateral Upper Limb Training and Bilateral Upper Limb Training
    TIAN Jing, HE Zhijie, YANG Qing, LIU Jue, JIA Jie
    2022, 17(04):  360-364.  DOI: 10.3969/j.issn.1673-5765.2022.04.007
    Asbtract ( )   PDF (2915KB) ( )  
    References | Related Articles | Metrics
    Objective To compare the changes of oxyhemoglobin concentration and brain functional activation in stroke patients performing unilateral upper limb training task and bilateral upper limb training task by functional near-infrared spectroscopy (fNIRS). Methods The patients with unilateral stroke who received rehabilitation treatment from three rehabilitation hospitals in Shanghai from January to April 2021 were enrolled in this study. The patients were observed using portable functional near-infrared brain imaging equipment in two different task states: unilateral upper limb training and bilateral upper limb training. The changes of brain oxyhemoglobin concentration and functional activation (β value) of each brain region under the two task states were compared. Results A total of 31 stroke patients were included in the final analysis. The comparison of functional near-infrared brain imaging showed that the β value in the primary motor cortex (M1), supplementary motor area (SMA) and primary somatosensory cortex (S1) at the affected and healthy sides in the patients with bilateral upper limb training were higher than those in the patients with only affected upper limb training, with statistical difference. The mean levels of oxyhemoglobin in the M1, SMA and S1 brain area at the affected and healthy sides in the patients with bilateral upper limb training were higher than those in the patients with only affected upper limb training, with statistical difference.Conclusions Compared with unilateral affected upper limb training, bilateral upper limb training activated bilateral M1, SMA and S1 brain area more significantly after stroke.
    Association between Plasma Ceramides and Vascular Events: A Meta-analysis
    YANG Chengyuan, JIN Aoming, XU Jie, MENG Xia
    2022, 17(04):  365-372.  DOI: 10.3969/j.issn.1673-5765.2022.04.008
    Asbtract ( )   PDF (2387KB) ( )  
    References | Related Articles | Metrics
    Objective To explore the relationship between plasma ceramides (Cer) and risk of cardiocerebrovascular events in patients with cardiovascular risk factors. Methods The databases including PubMed, Embase, Web of Science, CNKI, Wanfang Data and VIP were retrieved to search for the clinical studies involving the association of Cer and the risk of major adverse cardiovascular events (MACE) or stroke or myocardial infarction. A tool for assessing risk of bias in non-randomised studies of interventions (ROBINS-Ⅰ) was used to assess the literature quality in this study. Cer indices included ceramide test 2 (CERT2) score and Cer components of CERT2. According to heterogeneity analysis, a fixed or random effect metaanalysis was performed to determine the relationship between the above Cer indices and cardiocerebrovascular events. Results A total of 7 cohort studies including 30 886 patients were included in this meta-analysis. The results showed that particular components of Cer (d18:1/16:0) (HR 1.13, 95%CI 1.02-1.24, P =0.013) was independent risk factors of MACE. However, no obvious association between Cer (d18:1/24:0) or Cer (d18:1/24:1) and MACE were observed. There were no obvious association between CERT2 and stroke or myocardial infarction.Conclusions Cer (d18:1/16:0) was the risk factor of MACE. CERT2 might not be a robust predictor of stroke or myocardial infarction.
    Application of Double-lumen Microcatherter in Endovascular Recanalization of Chronic Internal Carotid Artery Occlusion
    MO Ming, CHEN Zhongjun, FAN Tieping, ZHAO Xusheng, HU Teng, LI Di
    2022, 17(04):  373-379.  DOI: 10.3969/j.issn.1673-5765.2022.04.009
    Asbtract ( )   PDF (3556KB) ( )  
    References | Related Articles | Metrics
    Objective To explore the feasibility, safety and technical advantages of dual-lumen microcatheter in endovascular recanalization of chronic internal carotid artery occlusion (CICAO). Methods The clinical data of patients with CICAO who were treated with double-lumen microcatheter revascularization at Dalian Municipal Central Hospital from January to December 2020 were retrospectively analyzed. The immediate postoperative revascularization (mTICI), any stroke events (including ischemic and hemorrhagic stroke) and stent re-occlusion were observed at 30 days and during the 6- to 10-month after the procedure. Results A total of 6 eligible patients aged 43 to 83 years were included, with 5 males (83.3%)and 1 female (16.7%). There was 1 (16.7%) case with long segmental occlusion (occluded segment extending from the initial segment of internal carotid artery to above the distal C5 segment). The clinical presentation was ischemic stroke in 5 cases (83.3%) and recurrent TIA in 1 case (16.7%). Preoperative NIHSS scores ranged from 1 to 5, and mRS scores ranged from 1 to 2. All patients (6/6, 100%) achieved mTICI grade 3 recanalization after the procedure. 2 cases (33.3%) had residual stenosis <20% and 4 cases (66.7%) had residual stenosis <10% after the procedure. There were no stroke or death events during the follow-up period, and mRS score at the 6-month follow-up was 0-1. Conclusions Dual-lumen microcatheter for revascularization of chronic occlusion of internal carotid artery may be safe and effective.
    Analysis of Risk Factors of Femoral Artery Puncture Site Complications after Neuroendovascular Treatment
    PANG Ke, DENG Yongmei, LIANG Jianshu, KANG Kaijiang, SUN Liqian, MA Ning, MIAO Zhongrong
    2022, 17(04):  380-384.  DOI: 10.3969/j.issn.1673-5765.2022.04.010
    Asbtract ( )   PDF (2088KB) ( )  
    References | Related Articles | Metrics
    Objective To explore the clinical risk factors of postprocedural femoral artery puncture site complications in patients who received neuroendovascular therapy. Methods Patients who received neuroendovascular therapy through femoral artery puncture in Neurointervention Center, Beijing Tiantan Hospital, Capital Medical University from March to September 2019 were retrospectively analyzed. A multivariate analysis was used to analyze the clinical risk factors of puncture site complications, including errhysis, subcutaneous hematoma, retroperitoneal hematoma, pseudoaneurysm, and arteriovenous fistula of the lower extremities. Results A total of 1240 patients were enrolled in the study, including 76 cases (6.13%) with complications and 1164 (93.87%) cases without complications. The univariate analysis showed male, femoral artery suture, use of compressor, and postoperative hypertension were correlated with the complications. The multivariate analysis showed femoral artery suture (OR 2.371, 95%CI 1.467-3.831, P =0.001), use of compressor (OR 2.183, 95%CI 1.268-3.760, P =0.005), and postoperative hypertension (OR 1.778, 95%CI 1.004-3.151, P =0.049) were independent risk factors for puncture site complications. Conclusions For patients who underwent interventional therapy via femoral artery access, femoral

    artery suture, use of compressor and postoperative hypertension were independent risk factors for

    puncture

    Development Trends of Patents in Stroke Field in China Based on PatSnap
    WANG Ling, WANG Hao, WANG Yilong
    2022, 17(04):  385-392.  DOI: 10.3969/j.issn.1673-5765.2022.04.011
    Asbtract ( )   PDF (2981KB) ( )  
    References | Related Articles | Metrics
    Objective To analyze the development trends of patents in stroke field in China based on PatSnap patent information, and provide reference for the strategic decision and science and technology innovation of relevant government departments, enterprises and research institutions. Methods Based on the PatSnap patent database, the patent literatures in stroke field applied in Intellectual Property Administration of China from 2000 to 2020 were searched, and the application trends, main patent technologies and development trend, main applicants, important patents, patent licenses and other aspects were analyzed. Results In the past 20 years, the number of patents applied in stroke field in China summed up to 15 160, and the trend continued to grow. The main technologies focused on drugs for treatment of cardiovascular diseases, pharmaceutical preparations containing organic active ingredients, drugs for treatment of neurological diseases. The main applicants were foreign pharmaceutical companies such as Hoffman Laroche Co, Ltd, followed by domestic universities. Patents with the largest scale, the most claims and the highest market value were all applied by foreign subjects. Since 2004, the highest percentage of patent license per year was 3.12%. Conclusions In the field of stroke, foreign patent technologies had a great impact on Chinese technological innovation. The patent quantity and quality of domestic subjects urgently need to be improved. It is suggested that domestic subjects should pay attention to the undeveloped research field. The patent license should be encouraged to promote stroke research development in China. 【Key
    Societal and Equity Challenges for Brain Health Services. A User Manual for Brain Health Services (Part 6)
    Translators: JIANG Jiwei, WANG Linlin, JIANG Shirui, XU Jun, WANG Yongjun
    2022, 17(04):  393-397.  DOI: 10.3969/j.issn.1673-5765.2022.04.012
    Asbtract ( )   PDF (1982KB) ( )  
    Related Articles | Metrics
    Misdiagnosis of Tentorial Dural Arteriovenous Fistulae :Two Cases Report
    ZHANG Xia, YU Zhengyang, YU Dandan, TIAN Decai, YANG Zhonghua, LIU Liping
    2022, 17(04):  398-401.  DOI: 10.3969/j.issn.1673-5765.2022.04.013
    Asbtract ( )   PDF (3520KB) ( )  
    References | Related Articles | Metrics
    Multi-Sequence Magnetic Resonance Imaging Evaluation and Signals Interpretation of Cervical Artery Dissection
    BI Jingfeng, LI Linlin, LIU Xinyao, ZHANG Yingkui
    2022, 17(04):  402-406.  DOI: 10.3969/j.issn.1673-5765.2022.04.014
    Asbtract ( )   PDF (4191KB) ( )  
    References | Related Articles | Metrics
    Progress in Drugs Therapy for Non-disabling Ischemic Cerebrovascular Events
    LI Zhenhua, LIU Zhu, HU Quanzhong
    2022, 17(04):  407-412.  DOI: 10.3969/j.issn.1673-5765.2022.04.015
    Asbtract ( )   PDF (1671KB) ( )  
    References | Related Articles | Metrics
    The non-disabling ischemic cerebrovascular events (NICE) accounted for 50%- 60% of ischemic cerebrovascular diseases. In recent years, the treatment of NICE has made a major breakthrough from the initial mono anti-platelet therapy to double anti-platelet therapy (DAPT), and the previous studies suggested that the short-course DAPT for 21 days had higher efficacy and safety. Intravenous thrombolysis for NICE can increase the risk of bleeding, so it is still controversial whether NICE patients should receive thrombolysis. The NICE type, NIHSS score, thrombolysis time window and drug dose are influencing factors for thrombolysis. For NICE patients carrying CYP2C19 LOF gene, ticagrelor has better therapeutic effect than clopidogrel. In addition, polymorphism of other genes also has an impact on the prognosis of NICE. The research on gene polymorphism may become a new direction for stroke treatment in the future.
    Progress of the Relationship between TET2 Mutation Related Clonal Hematopoiesis of Indeterminate Potential and Stroke
    WENG Jiaxu, QIU Xin, LI Zixiao
    2022, 17(04):  413-417.  DOI: 10.3969/j.issn.1673-5765.2022.04.016
    Asbtract ( )   PDF (1662KB) ( )  
    References | Related Articles | Metrics
    Age-related clonal hematopoiesis of indeterminate potential (CHIP) promotes the development of atherosclerosis by activating inflammation, which increases the risk of cardiovascular diseases. As one of the most common epigenetic regulatory genes among CHIP, the mutations in the ten-eleven translocation-2 (TET2) gene can increase the transcription of inflammatory factors such as IL-1β in macrophages through histone deacetylation. Therefore, it accelerates the development of atherosclerotic plaque, and is related with increasing risk of stroke and poor prognosis. In the future, research on targeting TET2 and its related mechanism pathways may help explore new strategies to reduce the occurrence of stroke and improve the patients’ prognosis.
    Progress and Mechanism of Exosome in Ischemic Stroke
    ZHANG Dongxue, ZOU Wei
    2022, 17(04):  418-425.  DOI: 10.3969/j.issn.1673-5765.2022.04.017
    Asbtract ( )   PDF (1718KB) ( )  
    References | Related Articles | Metrics
    Ischemic stroke is a kind of ischemic cerebrovascular disease that leads to neuronal ischemia and hypoxia death and permanent neurological damage due to interruption of cerebral blood supply. Exosome is a special extracellular vesicle. It has lipid bilayer membrane, the ingredients of which contain lipids, proteins, DNA, RNA and other substances. Exosome can be used as a transport carrier to cross the blood-brain barrier, to complete information exchange and genetic material transfer between the cells. The process is crucial for the recovery of neurological function after ischemic stroke. MicroRNAs (miRNA/miR), as biomarkers and therapeutic targets of ischemic stroke, play an important role in the diagnosis, treatment and prognosis of ischemic stroke. In this paper, the mechanism and therapeutic value of exosomes in ischemic stroke and the therapeutic effect of exosomes derived from stem cells were reviewed.
    Cultivation and Teaching Experience of Postgraduates in Moyamoya Disease
    BAO Xiangyang, DUAN Lian
    2022, 17(04):  426-428.  DOI: 10.3969/j.issn.1673-5765.2022.04.018
    Asbtract ( )   PDF (1620KB) ( )  
    References | Related Articles | Metrics
    In recent years, the diagnosis rate of moyamoya disease has been increasing, which has become an important development direction of cerebrovascular disease. How to improve the quality of postgraduate education in moyamoya disease directly affects the specialty development in the future. This article mainly introduced our experience in the teaching of postgraduates in moyamoya disease. In addition to focusing on the cultivation of scientific research thinking, we also strengthened the training and improvement of clinical practice ability, especially in the aspect of surgical skills.
    Ethical Discussion on Artificial Intelligence Medical Devices in Stroke Diagnosis and Treatment
    SUN Wei, BAI Caizhen, XU Lingling, XIAO Shuping
    2022, 17(04):  429-432.  DOI: 10.3969/j.issn.1673-5765.2022.04.019
    Asbtract ( )   PDF (1628KB) ( )  
    References | Related Articles | Metrics
    Artificial intelligence (AI) medical devices are more and more widely used in stroke diagnosis and treatment. On the one hand, it can help improve the efficiency of stroke diagnosis and treatment; on the other hand, there are some potential ethical problems, including informed consent of stroke patients, privacy security, data comprehensiveness, scientific algorithm, diagnostic accuracy and developers responsibility, etc. The countermeasures to deal with the ethical problems of AI medical devices in stroke diagnosis and treatment include two aspects: firstly, to construct perfect ethical review norms in ethical review procedure, clarify the identity and responsibilities of informed agents, and hire independent consultants in computer science; secondly, to establish an accountability system of AI medical devices in clinical application, and strengthen the professional training and ethics education for AI medical devices users.